✦ LIBER ✦

374 PUBLICATION Biochemical markers of the risk for cardiovascular disease in women with early breast cancer treated with anastrozole

Book ID: 118622954
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 140 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)80672-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of BMI on serum estradiol and bon

Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole

✍ Kyvernitakis, I.; KnÃ¶ll, D.; Struck, M.; Hars, O.; Bauer, T.; Hadji, P. 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 462 KB

Preventive effect of risedronate on bone

Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer

✍ Sergi, Giuseppe; Pintore, Giulia; Falci, Cristina; Veronese, Nicola; Berton, Lin 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 213 KB

391 Higher Risk of Locoregional Recurren

391 Higher Risk of Locoregional Recurrences for Women Treated with Mastectomy Compared to Breast-Conserving Therapy in Postmenopausal Women with Early Breast Cancer Treated on the TEAM Trial

✍ M. van Hezewijk; E.T.M. Hille; H. Putter; D. Rea; A. Hasenburg; C. Markopoulos; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

The Risk of Ischemic Heart Disease With

The Risk of Ischemic Heart Disease With Adjuvant Endocrine Therapy in Postmenopausal Women With Early Stage Breast Cancer

✍ Abdel-Qadir, H.; Fischer, H.; Fu, L.; Amir, E.; Harvey, P.; Lee, D.S.; Rochon, P 📂 Article 📅 2013 🏛 Pulsus Group Inc 🌐 English ⚖ 273 KB

Letrozole or anastrozole for the prevent

Letrozole or anastrozole for the prevention of early recurrences in post menopausal women with early stage breast cancer: using number needed to treat (NNT) to compare benefit

✍ H. Ruqo; M. Rourke; G. Dranitsaris; S. Kaura 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Do adjuvant aromatase inhibitors increas

Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer : Meta-analysis of randomized trials

✍ Federica Cuppone; Emilio Bria; Sunil Verma; Kathleen I. Pritchard; Sonal Gandhi; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada‐Common Toxicity Criteria [version